Panacea Biotec Limited, a biotechnology company, engages in the research, development, manufacture, and marketing of vaccines, pharmaceutical formulations, nutraceuticals, and food and nutrition products in India and internationally. It operates through Vaccines and Pharmaceutical formulations & Nutrition segments. The company's product portfolio includes prescription products in various therapeutic areas, such as oncology, diabetes, gastro-intestinal care, nephrology, orthopedics, pain management, and fever; cold and cough; and betacoronavirus, SARS-CoV-2, typhoid conjugate, pneumococcal conjugate, tetravalent dengue, Mpox, and hepatitis A vaccines, etc. It also offers health supplement products; and paediatric nutrition products under the ChilRunFull, ChilRun 7+, and ChillRun No Sucrose brands. In addition, the company engages in the real estate business. It exports its products to approximately 50 countries. The company has collaboration agreements with the Russian Direct Investment Fund for producing Covid-19 vaccine, and Sputnik-V; and the Indian Council of Medical Research for clinical trials of DengiAll vaccine. Panacea Biotec Limited was incorporated in 1984 and is based in New Delhi, India.
Low
292.40
High
647.00
Low
350.05
High
364.95
Company's profit divided by outstanding shares.
Ratio of share price to its earnings per share.
Total number of outstanding shares.
Gap between today's open and yesterday's close.
Average daily traded volume.
Highest price reached in the last 30 days.
Lowest price reached in the last 30 days.
Highest price reached in the last six months.
Lowest price reached in the last six months.
Highest price reached in the last year.
Lowest price reached in the last year.
How Panacea Biotec Limited stacks up against its Biotechnology peers on price, valuation and the 52-week range. Tap any column header to sort.
| # | Name | Price | Chg % | P/E | EPS | Mkt Cap (Cr) | 1M % | 1Y % | 52W H/L |
|---|---|---|---|---|---|---|---|---|---|
| 1 | PANACEABIO Panacea Biotec Limited | 358.50 | 2.05% | 0.00 | -1.16 | 2,196 | 11.81% | 13.95% | 647.00 / 292.40 |
| 2 | ANTHEM ANTHEM BIOSCIENCES LTD | 858.50 | 0.01% | 84.37 | 10.18 | 48,195 | 3.43% | 3.93% | 977.55 / 579.15 |
| 3 | BIOCON Biocon Limited | 371.40 | 0.30% | 109.95 | 3.38 | 60,381 | 9.61% | 6.42% | 447.15 / 337.70 |
| 4 | BLUEJET Blue Jet Healthcare Limited | 542.00 | 0.73% | 40.01 | 13.55 | 10,259 | 8.14% | 18.85% | 692.90 / 325.00 |
| 5 | CONCORDBIO Concord Biotech Limited | 1,399.00 | 1.85% | 53.18 | 26.31 | 14,636 | 10.15% | 16.48% | 1,667.60 / 987.00 |
| 6 | DCAL Dishman Carbogen Amcis Limited | 149.60 | 5.00% | 145.83 | 1.03 | 2,357 | 14.39% | 43.27% | 306.00 / 128.50 |
| 7 | ONESOURCE ONESOURCE SPECL PHARMA L | 1,500.00 | 1.42% | 0.00 | -4.25 | 17,201 | 2.02% | 20.68% | 1,925.00 / 1,057.00 |
| 8 | SUPRIYA Supriya Lifescience Limited | 925.00 | 2.66% | 0.00 | 0.00 | 7,489 | 16.04% | 41.23% | 1,085.00 / 545.50 |
| 9 | ZOTA Zota Health Care Limited | 1,253.10 | 3.21% | 0.00 | -30.88 | 4,340 | 15.29% | 3.66% | 1,740.00 / 1,022.00 |